You are here
BIOMARCK PHARMACEUTICALS, LTD
UEI: YURLLY9DJHP8
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
MARCKS: A novel therapeutic target in uveitis
Amount: $197,556.00ABSTRACT Uveitisthe most common form of intraocular inflammationaccounts forof preventable blindness in the USTreatment options are limited to cortiscosteroids and or immunosuppressantsbut both of the ...
STTRPhase I2019Department of Health and Human Services National Institutes of Health -
A novel therapeutic approach for Acute Lung Injury/ARDS
Amount: $201,503.00DESCRIPTION (provided by applicant): The objective of the proposed project is to advance the development of novel peptides targeting MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) protein as p ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
Clinical Development of a Therapeutic Agent for COPD
Amount: $3,000,000.00DESCRIPTION (provided by applicant): Hypersecretion of mucus into the respiratory airways is a major contributing factor in several lung diseases, including chronic pulmonary disease (COPD), asthma, ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
Clinical Development of a Therapeutic Agent for COPD
Amount: $3,000,000.00DESCRIPTION provided by applicant Hypersecretion of mucus into the respiratory airways is a major contributing factor in several lung diseases including chronic pulmonary disease COPD asthma ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
Clinical Development a Therapeutic Agent for COPD
Amount: $2,990,000.00Hypersecretion of mucus into the respiratory airways is a major contributing factor in several lung diseases, including chronic pulmonary disease (COPD), asthma, cystic fibrosis, and bronchiectasis. D ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
Inhibition of Mucin Secretion in Murine Model of Asthma
Amount: $100,000.00DESCRIPTION (provided by applicant): Hypersecretion of mucus into the respiratory airways is a major factor in several lung diseases, including chronic bronchitis, asthma, cystic fibrosis, and bronchi ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health
